Psoriasis vulgaris: an evidence-based guide for primary care

EA Kupetsky, M Keller - The Journal of the American Board of …, 2013 - Am Board Family Med
Psoriasis vulgaris is a chronic, sometimes debilitating, inflammatory disorder with multiple
pathways of pathogenesis that can be associated with metabolic and cardiovascular …

Psoriasis and comorbid diseases: epidemiology

J Takeshita, S Grewal, SM Langan, NN Mehta… - Journal of the American …, 2017 - Elsevier
Psoriasis is a common chronic inflammatory disease of the skin that is increasingly being
recognized as a systemic inflammatory disorder. Psoriatic arthritis is a well-known …

Research gaps in psoriasis: opportunities for future studies

C Ryan, NJ Korman, JM Gelfand, HW Lim… - Journal of the American …, 2014 - Elsevier
Over the past 2 decades, considerable progress has been made to further elucidate the
complex pathogenesis of psoriasis, facilitating the development of a new armamentarium of …

Psoriasis and comorbid diseases: Implications for management

J Takeshita, S Grewal, SM Langan, NN Mehta… - Journal of the American …, 2017 - Elsevier
As summarized in the first article in this continuing medical education series, the currently
available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic …

Diagnosis and management of psoriasis

WB Kim, D Jerome, J Yeung - Canadian Family Physician, 2017 - cfp.ca
Objective To provide primary care clinicians with an up-to-date and practical overview of the
diagnosis and management of psoriasis. Quality of evidence PubMed, MEDLINE, EMBASE …

Psoriasis: the future.

MA Menter, CE Griffiths - Dermatologic clinics, 2015 - europepmc.org
The umbrella term psoriasis is now understood to incorporate several distinct phenotypes or
endotypes along the disease spectrum that in turn will dictate different therapies. A stratified …

Psoriasis and psoriatic spectrum disease: a primer for the primary care physician

J Bilal, SU Malik, IB Riaz, DJB Kurtzman - The American Journal of …, 2018 - Elsevier
Psoriasis is a chronic, immune-mediated disorder that affects approximately 7.5 million
people in the United States. Individuals with psoriasis may develop cutaneous, articular, and …

Psoriasis: which therapy for which patient: psoriasis comorbidities and preferred systemic agents

SB Kaushik, MG Lebwohl - Journal of the American Academy of …, 2019 - Elsevier
Psoriasis is a systemic inflammatory disease associated with increased risk of comorbidities,
such as psoriatic arthritis, Crohn's disease, malignancy, obesity, and cardiovascular …

Update on the epidemiology and systemic treatment of psoriasis

SK Kurd, SK Richardson, JM Gelfand - Expert review of clinical …, 2007 - Taylor & Francis
Recent epidemiological observations reveal that the prevalence of psoriasis increases more
rapidly in young women compared with young men, and that the prevalence of psoriasis …

Psoriasis and comorbidities: links and risks

C Ni, MW Chiu - Clinical, cosmetic and investigational dermatology, 2014 - Taylor & Francis
Psoriasis is a chronic inflammatory skin disease affecting approximately 2% of the
population worldwide. In the past decade, many studies have drawn attention to comorbid …